The
following financial instruments were not included in the diluted loss per share calculations as of December 31, 2025 and December 31,
2024 because their effect was anti-dilutive:
Schedule of Anti-dilutive Loss Per Share
| | |
December
31, 2025 | | |
December
31, 2024 | |
| Warrants to purchase common stock | |
| 351,528 | | |
| 351,537 | |
| | |
| | | |
| | |
| Options | |
| 2,011,269 | | |
| 545,043 | |
| | |
| | | |
| | |
| Restricted stock awards units | |
| 436,786 | | |
| 424,656 | |
| | |
| | | |
| | |
| Total | |
| 2,799,583 | | |
| 1,321,236 | |
|